Zhaoke Ophthalmology Won the “Best Small and Mid-Cap Company” Award at the “Embracing 2023: the Seventh Golden Hong Kong Stocks Annual Awards Ceremony”

Zhaoke Ophthalmology Reaches Exclusive Distribution Agreement to Commercialize TONO-i in Greater China for Self-Measurement of Intraocular Pressure

Zhaoke Ophthalmology’s Partner Vyluma Announces Positive Results from Phase III CHAMP Study of NVK002 for Treatment of Myopia Progression in Children

Zhaoke Ophthalmology Named as a “China Top 30 Innovative Small Molecule Drug Developer” on the “2021 China Top 100 Innovative Biotech Companies List”

Zhaoke Ophthalmology Announces 2022 Interim Results